Role of IL-1 Family Cytokines IL-36, IL-37, IL-38 in Osteoarthritis and Rheumatoid Arthritis: A Comprehensive Review
Yuan Xu,Jing-Yan Wang,Yang Zou,Xue-Wei Ma,Tian Meng
DOI: https://doi.org/10.2147/jir.s474879
IF: 4.5
2024-06-21
Journal of Inflammation Research
Abstract:Yuan Xu, Jing-Yan Wang, Yang Zou, Xue-Wei Ma, Tian Meng College of Health Industry, Sichuan Tourism University, Chengdu, Sichuan, 610100, People's Republic of China Correspondence: Yuan Xu, Email Inflammatory cytokines, interleukin-36 (IL-36), IL-37, IL-38 belong to IL-1 family. The IL-36 subfamily obtains pro- and anti-inflammatory effects on various immune responses. Cytokine IL-37, has anti-inflammatory functions in immunity, and the recently identified IL-38 negatively associated with disease pathogenesis. To date, expression of IL-36, IL-37, IL-38 is reported dysregulated in osteoarthritis (OA) and rheumatoid arthritis (RA), and may be disease markers for arthritis-related diseases. Interestingly, expression of IL-38 was different either in OA patients or animal models, and expression of IL-36Ra in synovium was different in OA and RA patients. Moreover, functional studies have demonstrated significant role of these cytokines in OA and RA progress. These processes were related to immune cells and non-immune cells, where the cytokines IL-36, IL-37, IL-38 may regulate downstream signalings in the cells, and then involve in OA, RA development. In this review, we comprehensively discuss recent advancements in cytokines and the development of OA, RA. We hope that targeting these cytokines will become a potential treatment option for OA and RA in the future. Keywords: IL-36, IL-37, IL-38, osteoarthritis, rheumatoid arthritis Cytokines in IL-1 family consist of 7 agonists (such as IL-36α/β/γ), four cytokines having anti-inflammatory activities (such as IL-36Ra, IL-37, IL-38). 1–6 In recent years, the IL-36 subfamily, IL-37, IL-38 are recognized important in various immune response. Interleukin-36 subfamily includes IL-36α/β/γ, IL-36Ra, IL-36R, and IL-1RAcP. 1,2 IL-36 was previously considered as an IL-1 family cytokine that is able to induce generation of pro-inflammatory cytokines and activate MAPK and NF-κB signalings. This cytokine was mainly discussed in psoriasis in the past years. 7 IL-36 subfamily has sequence homology with IL-1α/β of 21–37%. Interluekin-36Ra shows 52% sequence homology with IL-1Ra. Interleukin-36α/β/γ bind to IL-36R, and then, may play pro-inflammatory functions. Interleukin-36Ra bound to IL-36R, may play anti-inflammatory functions. The IL-36 subfamily is expressed in various non-immune cells, including epithelial cells, keratinocytes, and in immune cells, including monocytes and T cells. Interleukin-37 (IL-37) was formerly recognized as the IL-1 family member 7. It was a new member of IL-1 family. 8 Its molecular weight is approximately 17–25 kDa. It contains five splice variants (IL-37a/b/c/d/e). Interleukin-37b/c has exon 1, exon 2. Interleukin-37b is the most abundant isoform. Interleukin-37 was widely expressed, including the thymus, bone marrow, monocytes. 3,4 Interleukin-37 is considered to have anti-inflammatory functions. Interleukin-38 (IL-38) was initially cloned as an IL-1 family cytokine as well, and it was called IL-1HY2 in year 2001. 9 The human IL-38 gene is located at chromosome 2p13, having 4 exons. Interleukin-38 is a 17–18 kDa protein. Interleukin-38 binds to IL-36R, showing anti-inflammatory functions among different immune responses. 5,6 Interestingly, these cytokines were reported to involve in arthritic diseases pathogenesis. Osteoarthritis (OA) and rheumatoid arthritis (RA) were two important arthritic disorders. 10,11 Inflammation is a marker of OA and RA pathogenesis. OA is the most common chronic degenerative joint disease. 12 Subchondral bone remodeling dysfunction featured by overactivated osteoclastogenesis may result in articular cartilage degeneration, OA progression. This process may relate to overactivated osteoclasts in subchondral bone, which will lead to type-H vessels and increased oxygen concentrations, and finally result in cartilage degeneration. 13 Treatment by regenerative methods including tissue engineering methods was established recently, which is potential for early treatment of cartilage degeneration in OA joints. 14 It is known that plant extracellular vesicles are nanoscale particles encapsulated by phospholipid bilayers, and can promote intercellular communication via transporting various bioactive molecules. Owing to their safety, abundant sources, good biocompatibility, they were recognized to be potential platform for treatment of RA. 15 Moreover, development of engineered microorganism-based delivery systems may also be used for these diseases treatment. 16 However, treatment of OA and RA is limited. To date, several studies have discussed the expression profile of IL-36, IL-37, IL-38 in OA and RA. Functional studies have also discussed the effects of these cytokines on the progress of OA, RA -Abstract Truncated-
immunology